Long-Term Follow Up of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).

Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Michael B. Maris; Judith Shizuru; Jose Leis; Edward Agura; Thomas Chauncey; Michael Pulsipher; Peter McSweeney; James Wade; Benedetto Bruno; Amelia Langston; Jerry Radich; Dietger Niederwieser; Karl Blume; Rainer Storb; and David G. Maloney